Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 13, Pages 11337-11345
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2011-02-01
DOI
10.1074/jbc.m111.223503
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A proximity ligation assay using transiently transfected, epitope-tagged proteins: application for in situ detection of dimerized receptor tyrosine kinases
- (2010) Aaron Gajadhar et al. BIOTECHNIQUES
- HER Kinase Axis Receptor Dimer Partner Switching Occurs in Response to EGFR Tyrosine Kinase Inhibition despite Failure to Block Cellular Proliferation
- (2010) A. Jain et al. CANCER RESEARCH
- Kinase-mediated quasi-dimers of EGFR
- (2010) Erez M. Bublil et al. FASEB JOURNAL
- Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments
- (2010) Fabrício F T Barros et al. HISTOPATHOLOGY
- EGFR Signaling and Drug Discovery
- (2010) Georg Lurje et al. ONCOLOGY
- Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts
- (2009) C. Larbouret et al. ANNALS OF ONCOLOGY
- Microbead Arrays for the Analysis of ErbB Receptor Tyrosine Kinase Activation and Dimerization in Breast Cancer Cells
- (2009) Imran H. Khan et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- ErbB receptors and signaling pathways in cancer
- (2009) Nancy E Hynes et al. CURRENT OPINION IN CELL BIOLOGY
- A Novel Proximity Assay for the Detection of Proteins and Protein Complexes: Quantitation of HER1 and HER2 Total Protein Expression and Homodimerization in Formalin-fixed, Paraffin-Embedded Cell Lines and Breast Cancer Tissue
- (2009) Yining Shi et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- HER-dimerization inhibitors: evaluating pertuzumab in women's cancers
- (2009) Katrin Kristjansdottir et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization
- (2009) J. B. Hughes et al. MOLECULAR CANCER THERAPEUTICS
- Flow Cytometric FRET Analysis of erbB Receptor Interaction on a Cell-by-Cell Basis
- (2008) Simone Diermeier-Daucher et al. Annals of the New York Academy of Sciences
- Interaction of antibodies with ErbB receptor extracellular regions
- (2008) Karl R. Schmitz et al. EXPERIMENTAL CELL RESEARCH
- EGFR family: Structure physiology signalling and therapeutic targets†
- (2008) Antony W. Burgess GROWTH FACTORS
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now